| Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference J Floege, SJ Barbour, DC Cattran, JJ Hogan, PH Nachman, SCW Tang, ... Kidney international 95 (2), 268-280, 2019 | 304* | 2019 |
| Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference BH Rovin, DJ Caster, DC Cattran, KL Gibson, JJ Hogan, MJ Moeller, ... Kidney international 95 (2), 281-295, 2019 | 182 | 2019 |
| Sexual and gonadal dysfunction in chronic kidney disease: Pathophysiology M Rathi, R Ramachandran Indian journal of endocrinology and metabolism 16 (2), 214-219, 2012 | 142 | 2012 |
| Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study L Senthil Nayagam, A Ganguli, M Rathi, HS Kohli, KL Gupta, K Joshi, ... Nephrology Dialysis Transplantation 23 (6), 1926-1930, 2008 | 132 | 2008 |
| Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis M Rathi, A Goyal, A Jaryal, A Sharma, PK Gupta, R Ramachandran, ... Kidney international 89 (1), 235-242, 2016 | 124 | 2016 |
| The adverse effect of COVID pandemic on the care of patients with kidney diseases in India N Prasad, M Bhatt, SK Agarwal, HS Kohli, N Gopalakrishnan, E Fernando, ... Kidney international reports 5 (9), 1545-1550, 2020 | 112 | 2020 |
| Tacrolimus combined with corticosteroids versus M odified P onticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial R Ramachandran, HK Hn, V Kumar, R Nada, AK Yadav, A Goyal, ... Nephrology 21 (2), 139-146, 2016 | 104 | 2016 |
| Natural medicines causing acute kidney injury V Jha, M Rathi Seminars in nephrology 28 (4), 416-428, 2008 | 101 | 2008 |
| PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians R Ramachandran, V Kumar, A Kumar, AK Yadav, R Nada, H Kumar, ... Nephrology Dialysis Transplantation 31 (9), 1486-1493, 2016 | 94 | 2016 |
| Referral pattern of end-stage renal disease patients and its impact on outcome at a public sector hospital S Parameswaran, SB Geda, M Rathi, HS Kohli, KL Gupta, V Sakhuja, ... Natl Med J India 24 (4), 208-213, 2011 | 93* | 2011 |
| Do healthy potential kidney donors in India have an average glomerular filtration rate of 81.4 ml/min? S Barai, GP Bandopadhayaya, CD Patel, M Rathi, R Kumar, D Bhowmik, ... Nephron Physiology 101 (1), p21-p26, 2005 | 75 | 2005 |
| Changing histologic spectrum of adult nephrotic syndrome over five decades in north India: A single center experience M Rathi, RL Bhagat, P Mukhopadhyay, HS Kohli, V Jha, KL Gupta, ... Indian journal of nephrology 24 (2), 86-91, 2014 | 53 | 2014 |
| Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes M Mackay, M Dall'Era, J Fishbein, K Kalunian, M Lesser, ... Arthritis & rheumatology 71 (3), 411-419, 2019 | 51 | 2019 |
| Two-year follow-up study of membranous nephropathy treated with tacrolimus and corticosteroids versus cyclical corticosteroids and cyclophosphamide R Ramachandran, AK Yadav, V Kumar, VST Pinnamaneni, R Nada, ... Kidney international reports 2 (4), 610-616, 2017 | 51 | 2017 |
| Deficiency of adenosine deaminase 2 in adults and children: experience from India A Sharma, G Naidu, V Sharma, S Jha, A Dhooria, V Dhir, P Bhatia, ... Arthritis & Rheumatology 73 (2), 276-285, 2021 | 50 | 2021 |
| ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review A Prabhahar, G Naidu, P Chauhan, A Sekar, A Sharma, A Sharma, ... Rheumatology International 42 (4), 749-758, 2022 | 48 | 2022 |
| Clinical features and long‐term outcomes of 105 granulomatosis with polyangiitis patients: a single center experience from north India A Sharma, GS Naidu, M Rathi, R Verma, M Modi, B Pinto, K Sharma, ... International Journal of Rheumatic Diseases 21 (1), 278-284, 2018 | 42 | 2018 |
| Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience R Ramachandran, V Kumar, M Rathi, R Nada, V Jha, KL Gupta, ... Nephrology Dialysis Transplantation 29 (10), 1918-1924, 2014 | 42 | 2014 |
| Connective tissue disorder-associated vasculitis A Sharma, A Dhooria, A Aggarwal, M Rathi, V Chandran Current rheumatology reports 18, 1-10, 2016 | 40 | 2016 |
| Rheumatological diseases and kidneys: a nephrologist's perspective T Mittal, M Rathi International Journal of Rheumatic Diseases 17 (8), 834-844, 2014 | 40 | 2014 |
Vivekanand JhaExecutive Director, George Institute for Global Health, India; Chair of Global Kidney HealthVerified email at georgeinstitute.org.in
